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ABSTRACT
In vitro reconstitution of the bacteriophage T4
replication machinery provides a novel system for
fast and processive isothermal DNA amplification.
We have characterized this system in two formats:
(i) in circular nicking endonuclease-dependent amp-
lification (cNDA), the T4 replisome is supplemented
with a nicking endonuclease (Nb.BbvCI) and a
reverse primer to generate a well-defined uniform
double-stranded linear product and to achieve up
to 1100-fold linear amplification of a plasmid in 1h.
(ii) The T4 replisome with its primase (gp61) can also
support priming and exponential amplification of
genomic DNA in primase-based whole-genome
amplification (T4 pWGA). Low amplification biases
between 4.8 and 9.8 among eight loci for 0.3–10ng
template DNA suggest that this method is indeed
suitable for uniform whole-genome amplification.
Finally, the utility of the T4 replisome for isothermal
DNA amplification is demonstrated in various appli-
cations, including incorporation of functional tags
for DNA labeling and immobilization; template gen-
eration for in vitro transcription/translation and
sequencing; and colony screening and DNA
quantification.
INTRODUCTION
In vitro DNA ampliﬁcation is essential for a wide range
of experiments in modern medical and biological re-
search, including applications such as forensic analysis,
disease diagnostics, cloning, sequencing and genotyping.
The polymerase chain reaction (PCR) is the most
commonly used method for DNA ampliﬁcation (1).
Thermal cycling between three temperatures for DNA
melting, primer annealing and DNA synthesis requires a
thermostable DNA polymerase. The ampliﬁed sequence
between the two oligonucleotide primers acts as the
template in the next cycle, leading to exponential ampliﬁ-
cation. However, a number of features limit the utility of
PCR. For example, whole-genome ampliﬁcation (WGA)
(2–5) by PCR is handicapped by the requirement for
thermal cycling instrumentation, size constraints on the
ampliﬁed DNA and the preferential ampliﬁcation of
some sequences compared to others (ampliﬁcation bias).
These limitations have spurred the development of a
range of isothermal DNA ampliﬁcation strategies as alter-
natives to PCR-based methods (6,7). For example, strand
displacement ampliﬁcation (SDA) (8,9) and loop-mediated
isothermal ampliﬁcation (LAMP) (10,11) are widely used
for the detection of pathogens. However, their inability to
efﬁciently amplify sequences longer than 200bp limits the
scope of possible applications. Rolling circle ampliﬁcation
(RCA) (12) generates, in analogy to the in vivo process,
multiple copies of a circular template. The Bacillus
subtilis bacteriophage Phi29 DNA polymerase is
normally used forRCA due to its high strand-displacement
activity and processivity. This DNA polymerase is able to
synthesize DNA strands longer than 70kbp (13). However,
the observed ampliﬁcation factor for templates of the size
of a plasmid is very low ( 20 times per hour), limiting
linear RCA to very small circular templates (14). To
broaden its scope for ampliﬁcation of whole plasmids,
multiple random hexameric primers have been used
(multiply primed RCA) (14). Up to 10000-fold ampliﬁca-
tion can be achieved and the hyperbranched product is on
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isothermal as it requires an initial heat denaturation step to
facilitate primer annealing.
Based on the same principle—random primers that are
extended by the Phi29 DNA polymerase—linear genomes
can also be ampliﬁed. The method adapted for WGA was
termed multiple displacement ampliﬁcation (MDA) (2)
and was the ﬁrst isothermal DNA ampliﬁcation method
used for WGA. In contrast to PCR-based WGA methods
using degenerate oligonucleotide primers (DOP-PCR)
(3,4) or 15-mer random primers (primer extension
preampliﬁcation, PEP) (5), MDA has the advantages of
low ampliﬁcation bias and increased product length (2).
An additional method, GenomePlex (15,16), has an
ampliﬁcation bias comparable to MDA (17), but
employs a relatively complicated workﬂow involving
cleavage of genomic DNA into fragments with an
average size of 400bp, ligation to adaptor sequences and
PCR ampliﬁcation. In addition, the short products are
unsuitable for applications such as restriction fragment
length polymorphism analysis and subcloning.
To create a truly isothermal method, the initial DNA
melting step can be obviated by including a helicase for
separating the two complementary DNA strands.
The helicase also eliminates the need for the strand
displacement activity of the DNA polymerase. Several
helicase-dependent ampliﬁcation (HDA) systems (18–20)
have been reported and fragments of up to 1500bp can
be ampliﬁed (20). The bacteriophage T7 replication ma-
chinery (consisting of the T7 helicase, T7 DNA polymerase
plustheEscherichiacolithioredoxinandT7single-stranded
DNA binding protein) makes it possible to amplify frag-
ments in the kilobase pairs range from circular templates
(cHDA). Here, a fragment deﬁned by two speciﬁc primers
is ampliﬁed as well as high-molecular-weight concatemers
of the circular template DNA by a rolling circle mechanism
(21). By also including the T7 primase function (which is
present in the same protein as the helicase activity), the
replisome can synthesize its own RNA primers that then
do not have to be supplemented. This method is not only
used for ampliﬁcation of plasmids, but also of genomic
DNA. Primase-based whole-genome ampliﬁcation
(pWGA)ischaracterizedbyampliﬁcationfactorsandamp-
liﬁcation bias comparable to MDA (22).
In this study, we describe the use of the T4 replisome as
an alternative system for isothermal DNA ampliﬁcation.
The complete T4 replication machinery consists of eight
proteins (23) (Figure 1). Gp43 is one of the fastest
polymerases known with a rate of  250nt/s when com-
plexed with its sliding clamp, gp45 (24,25).
Its exonuclease-deﬁcient variant gp43[D219A] has similar
activity (26). The clamp loader proteins (gp44/62) are
required for loading gp45 onto the replication fork in an
adenosine triphosphate (ATP)-dependent process. The
helicase (gp41), assembled by the helicase loader (gp59),
unwinds DNA at a rate of  400nt/s (27) using the energy
from ATP hydrolysis. Gp32 interacts with the exposed
ssDNA and is involved in multiple protein–protein inter-
actionsintheT4replisome. TheT4replisomereconstituted
with these seven proteins is highly processive and can thus
synthesize leading-strand DNA larger than 20kbp (25).
The primase (gp61) that forms the primosome together
with the helicase recognizes the 50-GTT-30 and 50-GCT-30
primingrecognitionsitesandsynthesizes5ntRNAprimers
(28) for initiation of lagging-strand DNA synthesis.
We characterize this system for isothermally amplifying
plasmids as well as whole genomes. We also describe a
new mechanism for isothermally amplifying whole
plasmids avoiding the generation of high-molecular-
weight concatemers in a circular nicking endonuclease-
dependent ampliﬁcation (cNDA). The high synthesis
rate of the T4 replisome allows a whole plasmid
(4.7kbp) to be ampliﬁed up to 1100-fold in 1h, although
the ampliﬁcation is linear and not exponential. In pWGA
human genomic DNA was ampliﬁed up to 210-fold in 1h
using the T4 replisome (T4 pWGA), exhibiting low
ampliﬁcation biases (i.e. the ratio of the highest to the
lowest ampliﬁcation factor) between 4.8 and 9.8 among
the eight loci tested for three different amounts of input
DNA (0.3, 1 and 10ng).
MATERIALS AND METHODS
Protein expression and puriﬁcation
The T4 replisome proteins gp43[D219A] (26), gp59 (29),
gp44/62 (30), gp45 (31), gp41 (31) and gp61 (28) were
expressed and puriﬁed as previously described. Typical
protein yields (in mg puriﬁed protein/l culture) were
50mg/l for gp45; 13mg/l for gp44/62; 5mg/l for gp43,
gp59 and gp61; and 1mg/l for gp41. Gp32 and the
nicking endonuclease Nb.BbvCI were purchased from
New England BioLabs (NEB).
Plasmids for cNDA
The following circular plasmids were used as templates for
cNDA:
(i) pIVEX-GFP (4429bp) was constructed from
pIVEX2.6d (Roche Applied Science) and contains
the gene coding for GFP as described in Courtois
et al. (32). A recognition site for the nicking endo-
nuclease Nb.BbvCI was inserted into the NheI site:
Two complementary 50-phosphorylated oligonucleo-
tides (50-PO3-CTAGCATTCTGTACCTAATGAG
CTGAGGAGAACTTGAGACG-30 and 50-PO3-CT
AGCGTCTCAAGTTCTCCTCAGCTCATTAGG
TACAGAATG-30, Invitrogen) were annealed and
ligated into the plasmid pIVEX-GFP previously
digested with NheI and dephosphorylated with calf
intestinal alkaline phosphatase (CIP). The selected
clone was sequenced and contained the nicking site
once in the sense strand.
(ii) pIVEX-RFP (4289bp) was constructed from
pIVEX2.6d and contains the gene coding for the
monomeric red ﬂuorescent protein mRFP1 (33,34)
between the restrictions sites NdeI and SalI.
A recognition site for the nicking endonuclease
Nb.BbvCI was inserted into the NheI site as
described for pIVEX-GFP. The selected clone was
sequenced and contained the nicking site twice in
the anti-sense strand.
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as described in Stein et al. (35). A recognition
site for the nicking endonuclease Nb.BbvCI was
inserted into the EcoRI site: Two complementary
50-phosphorylated oligonucleotides (50-PO3-AATTC
TGTACCTAATGACCTCAGCATACGAACTTG
ATGCAGACG-30 and 50-PO3-AATTCGTCTGCA
TCAAGTTCGTATGCTGAGGTCATTAGGTAC
AG-30, Invitrogen) were annealed and ligated into
the plasmid pIVEX-AGT-GST previously digested
with EcoRI and dephosphorylated with calf
intestinal alkaline phosphatase (CIP). The selected
clone was sequenced and contained the nicking site
once in the sense strand.
(iv) pIVEX-PTE (4597bp) contains the
phosphotriesterase (PTE) gene from Pseudomonas
diminuta between the restriction sites BglII and
BamHI in the pIVEX backbone (36). A recognition
site for the nicking endonuclease Nb.BbvCI was
inserted into the EcoRI site: two complementary
50-phosphorylated oligonucleotides (50-PO3-AATTC
TGTACCTAATGAGCTGAGGATACGAACTTG
ATGCAGACG-30 and 50-PO3-AATTCGTCTGCA
TCAAGTTCGTATCCTCAGCTCATTAGGTAC
AG-30, Invitrogen) were annealed and ligated into
the plasmid pIVEX-PTE previously digested with
EcoRI and dephosphorylated with calf intestinal
alkaline phosphatase (CIP). The selected clone was
sequenced and contained the nicking site once in the
anti-sense strand.
cNDA reaction
Each reaction contained the following proteins: 2mM
gp32 (NEB), 200nM gp43, 200nM gp45 (trimer),
200nM gp44/62 (4:1 complex), 100nM gp59, 900nM
gp41 and 0.2U/ml Nb.BbvCI. The proteins were
normally added individually, but if desired, all the
proteins can be combined ﬁrst into a master mix and
then added at once to reduce the number of pipetting
steps. The buffer contained 1mM each dNTP, 2mM
ATP, 20mM Tris-acetate (pH 7.5), 150mM potassium
acetate, 10mM magnesium acetate and 0.4mM reverse
primer (Invitrogen) (Table 1). Unless otherwise stated,
primer b1 (Table 1) was utilized with 10ng of covalently
closed circular plasmid as the template in a reaction
volume of 20ml. Reactions were incubated for 1h at
37 C. Aliquots of 15ml were resolved by a 1% agarose
gel and stained with SYBR safe (Invitrogen; marker:
Hyperladder I, Bioline).
Real-time monitoring of cNDA
cNDA reactions were prepared as described above and
contained a 1  concentration of EvaGreen [Jena
Bioscience;  1.33mM (37)]. The real-time cNDA reactions
contained 0, 0.25, 1 or 4ng of pIVEX-GFP. They were
Figure 1. The bacteriophage T4 replisome. The bacteriophage T4 replisome is composed of eight proteins. The hexameric helicase (gp41) and
oligomeric primase (gp61) constitute the primosome. Gp41 requires the helicase loader (gp59) for effective loading on the replication fork.
Double-stranded DNA is unwound by the helicase. The single-stranded DNA thus generated is prevented from reannealing by binding of gp32.
Gp61 synthesizes pentaribonucleotide primers (blue) that are then extended by the DNA polymerase (gp43). The polymerase, the clamp gp45 (trimer)
and clamp loader proteins (gp44/62) form the holoenzyme. Gp45 increases the processivity of the polymerase and is loaded by gp44/62.
Table 1. Sequences of reverse primers used for cNDA reactions
Name Sequence (50-30)
b1
a GCTCATTAGG
b2
b GAGCACTGTC
b3
a GCTCATTAGGTACAGAAT
b4
a GCATACGAACTTGATGCAGA
Nb1
c CATGCACATC
Nb2
c TCTAGGGCGG
biotin-b1
a Biotin-GCTCATTAGG
aComplementary to the inserted cassette for the nicking endonuclease.
bComplementary to a constant region in pIVEX.
cWithout a complementary sequence in the templates used.
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machine at 37 C for 6h recording green ﬂuorescence (lex-
citation: 470nm, lemission: 510nm) every 3min.
Determination of the ampliﬁcation factor in cNDA
cNDA reactions with primer b4 were prepared as
described above and included 8ng, 0.8ng, 80pg or 8pg
of pIVEX-AGT-GST. Aliquots of 15ml were resolved by a
1% agarose gel and stained with ethidium bromide.
Aliquots were diluted 100-fold and analysed by quantita-
tive PCR (qPCR) in a Rotor-Gene 6000 instrument
(Corbett) using SYBR Green I as the detection dye.
DNA amounts were determined relative to a standard
ladder of pIVEX-AGT-GST. The experiment also
included controls with no template. A SensiMix SYBR
No-ROX Kit (Quantace) was used according to the manu-
facturer’s instructions. The total reaction volume was 25ml
and included 2ml diluted samples. The primers (50-TCCA
AAAGAGCGTGCAGAGAT-30) and (50-TGCAATTCT
CGAAACACCGTAT-30) were used at a concentration of
0.8mM. The thermal cycling conditions were 95 C for
10min followed by 40 cycles of 10s at 95 C, 30s at
60 C and 10s at 72 C. At the end of the qPCR, a
melting curve analysis (60–95 C) was performed. qPCR
measurements were performed in duplicate for each
sample. Data were analysed with Rotor-Gene 6000
software 1.7 in the dynamic tube normalization mode.
cNDA from single colonies
Electrocompentent E. coli DH5a cells (Invitrogen) were
transformed with the plasmid pIVEX-RFP and plated
on agar plates containing 100mg/ml ampicillin. A colony
of  60000 cells (determined by serial dilution and plating)
was picked and lysed at 95 C for 3min in the presence of
all cNDA components except the proteins. After chilling
on ice, the proteins were added to the reaction to a ﬁnal
volume of 20ml. Then the cNDA reaction was carried out
as described above.
cNDA prior to in vitro transcription and translation
cNDA reactions with primer b3 were prepared as
described above and included 0, 0.066 or 0.66ng of
pIVEX-PTE. Ampliﬁcation was allowed to proceed for
1h at 37 C and then stopped by incubation at 80 C for
20min. Aliquots of 2ml were then directly added to 8mlo f
in vitro transcription and translation (IVTT) mixture
(RTS 100, E. coli HY kit, Roche Applied Science),
prepared according to the manufacturer’s instructions.
IVTT reactions were incubated at 30 C for 3h. The
assay for PTE activity was performed as described previ-
ously (38). Brieﬂy, 30ml of incubation buffer (50mM Tris-
HCl, 10mM K2CO3,2 5mM ZnCl2, pH 8.5) were added to
each of the 10ml IVTT samples followed by overnight
incubation at 16 C. Thereafter, 2ml of these samples
were assayed in triplicate with 0.25mM paraoxon in
50mM Tris-HCl (pH 8.5) in a total volume of 200ml.
The release of the 4-nitrophenolate product was moni-
tored at 405nm in a Spectramax M5 plate reader
(Molecular Devices) at 25 C. For the controls without
ampliﬁcation, the same amount of DNA (0, 0.066 or
0.66ng) was added to 1  T4 buffer (1mM each dNTP,
2mM ATP, 20mM Tris-acetate, 150mM potassium
acetate, 10mM magnesium acetate, pH 7.5). All the
other steps were carried out identically as described
above. Linear parts of the time courses (<20% of the
total reaction) were ﬁtted to compare initial rates.
Labeling and immobilization of cNDA products
cNDA reactions (40ml) were prepared as described above
and included either reverse primer b1 or biotin-b1.
pIVEX-PTE was used as the template at a concentration
of 20ng/40ml reaction (165pM) or 2ng/40ml reaction
(16.5pM). Ampliﬁcation was allowed to proceed for 1h
at 37 C and then stopped by incubation at 80 C for
20min. Aliquots of 15ml were resolved by a 1% agarose
gel and stained with SYBR safe (Invitrogen). Aliquots of
20ml were immobilized on 5ml streptavidin-coated
magnetic beads (10mg/ml, Dynabeads M-270
Streptavidin, Invitrogen) using the Dynal
kilobaseBINDER Kit (Invitrogen) according to the manu-
facturer’s instructions. After immobilization, beads were
resuspended in 10ml Milli-Q water of which 5ml were then
added to 20ml of IVTT mixture (RTS 100, E. coli HY kit,
Roche Applied Science), prepared according to the manu-
facturer’s instructions. IVTT reactions were incubated at
30 C for 3h. The IVTT sample was separated from the
magnetic beads with the aid of a magnet; 30ml of incuba-
tion buffer (50mM Tris-HCl, 10mM K2CO3,2 5 mM
ZnCl2, pH 8.5) were added to 10ml aspirated sample;
and after 2h at room temperature the assay was per-
formed as described in the previous paragraph.
T4 pWGA
Each reaction contained the following proteins: 2mM gp32
(NEB), 800nM gp43, 800nM gp45 (trimer), 800nM gp44/
62 (4:1 complex), 100nM gp59, 900nM gp41 and 900nM
gp61. The buffer contained 1mM each dNTP, 100mM
each rNTP, 2mM ATP, 20mM Tris-acetate (pH 7.5),
150mM potassium acetate and 10mM magnesium
acetate. Unless otherwise stated, 10ng of human
genomic DNA (Promega) was used as the template in a
total reaction volume of 20ml. Reactions were incubated
at 37 C for 1h and stopped by incubation at 80 C for
20min. Aliquots of 15ml were resolved by a 1% agarose
gel and stained with SYBR safe (marker: Hyperladder I,
Bioline).
Sequencing of ampliﬁcation products
pIVEX-GFP, pF3A WG (BYDV) Flexi Vector (Promega)
and pDONR221 (Invitrogen) were ampliﬁed as described
in the previous section, with the exception that 4ng of
plasmid were used in a 100ml reaction volume. The
products were puriﬁed with the QIAEX II kit (Qiagen)
and eluted with 50ml of 1mM Tris-HCl (pH 8.5). Each
ampliﬁcation product was sequenced with two different
primers (Supplementary Table S1). Sequencing (see SI)
was performed by the DNA sequencing facility of the
Biochemistry Department at the University of
Cambridge with an Applied Biosystems 3730xl DNA
Analyzer. The longest stretch of sequence that matched
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bases (N) was classiﬁed as ‘accurately sequenced’, even if a
longer stretch could be identiﬁed by inspection of the
chromatogram to identify bases originally labeled as N
by the automatic sequencer. This value provides a conser-
vative estimate of the accurately sequenced length.
Determining amplification factor and bias
The ampliﬁcation factors and biases of T4 pWGA were
compared with WGA by illustra GenomiPhi V2 DNA
Ampliﬁcation Kit (GE Healthcare) and Rapisome
pWGA Kit (BioHelix Corporation). Eight SNP loci
from different chromosomes were chosen to survey the
genome coverage. The sequences of the primers were
taken from Hosono et al. (39) and are given in Table 2.
The T4 replisome was used to amplify 0.3, 1 or 10ng of
puriﬁed human genomic DNA (obtained from Promega,
containing DNA of which 90% is longer than 50kb) in
triplicate 25ml reactions as described above in ‘T4
pWGA’. These amounts of DNA correspond to 90, 300
and 3000 genome copies, respectively. Rapisome pWGA
reactions were performed according to the manufacturer’s
instructions. Brieﬂy, 0.3, 1 or 10ng of puriﬁed human
genomic DNA (in 5ml Milli-Q water) were mixed with
20ml Rapisome master mix and incubated for 1h at
37 C. The reactions were stopped by incubation for
20min at 65 C. Illustra GenomiPhi V2 reactions were
performed according to the manufacturer’s instructions.
Brieﬂy, 0.3, 1 or 10ng of puriﬁed human genomic DNA
(in 1.25ml Milli-Q water) were mixed with 11.25ml sample
buffer and heated to 95 C for 3min. After cooling to 4 C
12.5ml master mix consisting of 11.25ml reaction buffer
and 1.25ml enzyme mix were added and incubated for
90min at 30 C. The reactions were stopped by incubation
for 10min at 65 C. Reactions were stored at  20 C until
analysed.
The ampliﬁcation factors were determined by qPCR
on a Roche Light Cycler 480 instrument using SYBR
Green I as the detection dye. DNA amounts were
determined relative to a standard ladder of human
genomic DNA (Promega) for each primer pair. The
qPCRs also included controls with no template. A
SensiMix SYBR No-ROX Kit (Quantace) was used
according to the manufacturer’s instructions. The total
reaction volume was 25ml and included samples at ﬁnal
dilutions of 125- to 313-fold. Primers (Table 2) were used
at a concentration of 0.5mM. The thermal cycling
conditions were 95 C for 10min followed by 45 cycles of
10s at 95 C, 15s at 60 C and 20s at 72 C. At the end
of each reaction, a melting curve analysis (60–95 C) was
performed. qPCR measurements were performed in
triplicate for each sample. Data were analysed
with the LightCycler 480 Software, version 1.5.0.39.
Absolute quantiﬁcation analysis was performed with the
second derivative maximum method (high-conﬁdence
algorithm).
Ampliﬁcation factors and standard deviations (SDs)
were calculated from triplicates of the WGA reactions
for each locus (Supplementary Table S2). SDs from the
qPCR triplicates of each sample were insigniﬁcant
compared to the SDs from the WGA reactions. The
averaged ampliﬁcation factors in Table 3 represent the
mean of the ampliﬁcation factors over the eight loci
analysed and the SDs represent the pooled standard devi-
ation of the SDs in individual loci. The ampliﬁcation bias
was calculated as the ratio of the highest to the lowest
ampliﬁcation factor among the eight loci.
Quantitative T4 pWGA
T4 pWGA reactions were prepared in duplicate as
described above and contained a 1  concentration of
EvaGreen [Jena Bioscience;  1.33mM (37)] and 0, 1pg,
10pg, 100pg or 1ng of human genomic DNA. They were
carried out in a Rotor-Gene 6000 qPCR instrument
(Corbett) at 37 C for 120min recording green ﬂuorescence
(lexcitation: 470nm, lemission: 510nm) every 2min. Analysis
was carried out using the Rotor-Gene 6000 software 1.7 in
the dynamic tube normalization mode.
RESULTS
Circular nicking endonuclease-dependent ampliﬁcation:
cNDA
We present an approach for isothermal DNA ampliﬁca-
tion of whole plasmids termed cNDA (Figure 2A). cNDA
yields a single well-deﬁned product, in contrast to other
isothermal DNA ampliﬁcation methods capable of amp-
lifying whole plasmids (i.e. multiply primed RCA and
cHDA). We utilized the T4 replisome for cNDA,
because its high processivity and DNA synthesis rate
result in substantial ampliﬁcation, despite a linear
(rather than exponential) ampliﬁcation scheme.
Table 2. Primers used for ampliﬁcation factor and locus bias studies
Chr WIAF
a forward primer (50-30) reverse primer (50-30)
1p 984 TTTGATGGAGAAATCCGAGG TCCCTAAATGACAAAAAGAGAAGG
2p 1004 GTCTTTAGCTGCTGAGGAAATG AGCAGAATTCTGCACATGACG
3q 979 AGAACCTGACCAGATGTGGC CAAACGTCAAGCTCAGTTTCC
5p 1331 GGGTAAGATCCAGAGCCACA CCTCATTCCTTCTCGAAGCA
10q 723 CTTCCTGACCTGTTTGCAGT CTTCAGTGCACAGAATGCAG
15q 244 GAGTTTAATGAATCCTGTTCCCC CTGTAATATAACCGTTTCATTCAGC
17q 699 TGCTCCCTGTCCCATCTG AGACAGTATGCCTTTATTTCACCC
21p 683 TGAGGCTATGATTGCAGATTT TCCCTAAATGACAAAAAGAGAAGG
aRefers to the Whitehead Institute-Affymetrix SNP database numbering of loci in the human genome.
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mented with a nicking endonuclease (e.g. Nb.BbvCI) and
a reverse primer. The nicking endonuclease recognizes a
speciﬁc sequence on the template and introduces a nick
into the double-stranded DNA. At this nick, the T4
replisome can initiate DNA ampliﬁcation using the
30-OH group exposed at the nick as a primer. In a
rolling circle fashion, the replisome replaces the nicked
strand with a newly synthesized one, while displacing the
old strand. The nicking endonuclease remaining in the
reaction mixture also nicks the newly synthesized strand.
If the nicking occurs before the replisome completes one
cycle around the template, the displaced strand is released
from the template. This released single-stranded copy of
the template is made double stranded by extending a
reverse primer. The result is a linear copy of the circular
plasmid (Figure 2B). A product of twice the size of the
template makes up <10% of the total ampliﬁed DNA.
This observation is consistent with a fraction of DNA
not being nicked when the T4 replisome arrives at the
nicking endonuclease recognition site.
Product identity, reaction components, speciﬁcity and
template preference of cNDA
To show that the cNDA product is indeed composed of
linear copies of the circular template, the template
(pIVEX-RFP) as well as the cNDA product were indi-
vidually and simultaneously digested by two restriction
enzymes, BbvCI and NdeI. The restriction endonuclease
BbvCI has the same recognition and cutting site as the
nicking endonuclease Nb.BbvCI. Therefore, no effect is
expected when the cNDA product is treated with BbvCI
(Figure 3B), whereas the template plasmid can be
linearized by BbvCI as well as by NdeI (Figure 3A).
If the cNDA product is digested with NdeI, two fragments
of 1and 3.3kbp are expected. The same fragments are
expected if the template plasmid is digested with BbvCI
and NdeI. Gel electrophoresis of these digests reveals frag-
ments of the expected sizes (Figure 3C). This observation
is consistent with the reaction mechanism for cNDA that
is proposed in Figure 2A.
Protein components required for cNDA were
determined by omitting one protein at a time from the
reaction mixture. All proteins included in the reaction
mixture were necessary for efﬁcient ampliﬁcation by the
T4 replisome (Supplementary Figure S1). No product
could be detected on an agarose gel when any one of
these proteins was absent (suggesting at least a 20-fold
decrease in reaction efﬁciency), except for gp59 (the
omission of which resulted in a smaller,  10-fold
decrease). These observations are consistent with
previous in vitro studies of the T4 replisome on small
circular substrates (40). The failure to amplify DNA in
the absence of the nicking endonuclease (Supplementary
Figure S1) suggests that the nick is essential for initiating
the DNA synthesis and that the low percentage of natur-
ally occurring nicks is not sufﬁcient to support efﬁcient
cNDA.
In cNDA, speciﬁcity is provided by the reverse primer
and by the nicking endonuclease (Supplementary
Figure S2). Different forms of circular DNA were tested
as templates for cNDA (Supplementary Figure S3). No
product was formed in the absence of template DNA.
Covalently closed circular plasmid, nicked circular
plasmid and heat-denatured plasmid were all ampliﬁed
with comparable efﬁciency.
Figure 2. Mechanism of cNDA. (A) One strand of the circular template is cut by the nicking endonuclase (1). The nick serves to initiate ampli-
ﬁcation by the T4 replisome (2). A new DNA strand is synthesized and single-stranded DNA is displaced (3). The nicking endonuclease also nicks
the newly synthesized strand (4). The displaced strand is released from the template as it is cut at the nicking site (5). The ssDNA is primed by the
reverse primer and the T4 replisome makes it double stranded (6). Linear copies of the circular template DNA result (7). (B) One single product of
cNDA after ampliﬁcation of the plasmid pIVEX-RFP.
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The progress of cNDA reactions was continuously moni-
tored for 6h. For this purpose, the dsDNA intercalating
dye EvaGreen (37) was added to cNDA reactions and the
reactions were carried out in a quantitative PCR (qPCR)
machine. Four cNDA reactions containing covalently
closed circular template DNA were monitored in real
time (Figure 4A). The progress curves were initially
linear with the slopes depending on the DNA substrate
concentration followed by ﬂattening to a plateau as one
of the reaction components became depleted. The lag
preceding the linear phase can be ascribed to the time
required to perform the following processes before the
ﬂuorescent signal crosses the detection threshold: loading
of the polymerase and clamp at the nick, slow
strand-displacement synthesis to create a ssDNA tail for
the helicase to load after which rapid synthesis can take
place, priming of the displaced ssDNA and loading of
another polymerase and clamp to convert the ssDNA to
dsDNA to which the EvaGreen binds resulting in a ﬂuor-
escent signal.
Ampliﬁcation factors were determined by qPCR for dif-
ferent amounts of template DNA (8pg to 8ng) after 1h of
cNDA. The ampliﬁcation products were also analysed on
a gel (Figure 4B). Ampliﬁcation factors between 170 and
1100 were detected: The lower the starting DNA concen-
trations, the higher the ampliﬁcation factors were.
The ampliﬁcation product from 8pg template could not
be detected on an agarose gel (Figure 4B), but a 1100-fold
ampliﬁcation was determined by qPCR.
Ampliﬁcation from single colonies
The ability to amplify plasmids by cNDA directly
from single colonies of bacteria was tested. Individual
colonies of E. coli cells carrying the plasmid
pIVEX-RFP were lysed in cNDA reaction buffer for
3min at 95 C. After addition of the proteins, cNDA
was performed. All three colonies picked were
ampliﬁed with similar efﬁciency, yielding a typical
cNDA band (Figure 5).
cNDA prior to in vitro transcription and translation
The ability of cNDA products to serve as templates for
in vitro transcription and translation (IVTT) and to
increase IVTT yields was assessed. We performed cNDA
of a plasmid (pIVEX-PTE) coding for a
phosphotriesterase (PTE) (36), expressed PTE following
the addition of an IVTT extract derived from E. coli and
assayed for degradation of the organophosphate pesticide
paraoxon by PTE (Figure 6). Three different amounts of
template DNA (0, 0.066ng and 0.66ng) were tested. For
comparison, the procedure was also performed without
prior DNA ampliﬁcation. Although no increase in the
background organophosphate hydrolysis rate was
observed for the no template controls (data not shown),
signiﬁcant increases in enzymatic rates of 14- and 67-fold
for the cNDA-ampliﬁed samples (for 0.066ng and 0.66ng
template, respectively) were observed compared to the
controls without prior cNDA.
Figure 3. Restriction digests of cNDA product. (A) The plasmid pIVEX-RFP (4.3kbp) was used as the template for ampliﬁcation. The recognition
site for the nicking endonuclease Nb.BbvCI used in cNDA is cut by the restriction enzyme BbvCI. If cut additionally with NdeI, two fragments with
the lengths of 1.04kbp and 3.26kbp are generated. (B) Expected product of cNDA. (C) The product of cNDA (lane 1) was cut with BbvCI (lane 2),
NdeI (lane 5) or BbvCI and NdeI (lane 6). The plasmid pIVEX-RFP (lane 8) was also digested with BbvCI (lane 3), NdeI (lane 4) or BbvCI and
NdeI (lane 7).
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One advantage of the cNDA reaction scheme is that labels
such as ﬂuorescent dyes or biotin can be introduced into
the product at a deﬁned position with a labeled reverse
primer. To demonstrate this principle, a reverse primer
carrying a biotin label was used to immobilize the
cNDA products on streptavidin-coated beads. cNDA re-
actions with a template coding for a PTE (10ng or 1ng
pIVEX-PTE) were performed. The cNDA yield was not
affected by the presence of a label on the primer
(Figure 7A). The labeled products were then immobilized
on streptavidin-coated magnetic beads and added to an
IVTT reaction. After protein expression, a PTE activity
assay was performed. PTE activity was detected only
when a biotinylated primer was used (Figure 7B). These
observations suggest that cNDA products were successful-
ly biotinylated, immobilized on streptavidin-coated beads
and from there transcribed and translated without signiﬁ-
cant binding of non-biotinylated DNA to the beads.
Alternatively, labeling throughout the whole amplicon is
also possible by incorporating modiﬁed nucleotides.
Supplementary Figure S4 shows a ﬂuorescent cNDA
product of a reaction including ﬂuorescein-dCTP
(equalling 5% of total dCTP).
Primase-based WGA with the T4 replisome
The T4 replisome is able to amplify DNA by random
priming in a similar way to multiply primed RCA and
MDA with Phi29 DNA polymerase (Supplementary
Figure S5). In addition, the ability of the T4 replisome
to amplify linear genomic DNA employing its primase
gp61 (T4 pWGA) was assessed. In contrast to cNDA,
the nicking endonuclease and primers were omitted and
gp61 and all four rNTPs were added instead.
Ampliﬁcation occurred when the concentration of the
holoenzyme (gp43, gp45 and gp44/62) was increased to
800nM to ensure efﬁcient primer transfer from the
primosome to the holoenzyme (41). The products of T4
pWGA of human genomic DNA were run on a 1%
agarose gel that indicates ampliﬁcation products of differ-
ent lengths (Figure 8).
Previous mechanistic studies of the T4 replisome
showed that the length of the Okazaki fragments
Figure 4. Real-time monitoring and ampliﬁcation factors of cNDA. (A) Twenty microlitres of cNDA reactions containing 4ng (red circles), 1ng
(green triangles), 0.25ng (blue diamonds) and 0ng (black squares) of template plasmid (pIVEX-GFP) were supplemented with the dsDNA
intercalating EvaGreen dye. The reactions were carried out in a qPCR machine (Rotor-Gene 6000, Corbett) at 37 C and the ﬂuorescence was
recorded every 3min for 6h. (B) Twenty microlitres of cNDA reactions containing 8ng (lane 1), 0.8ng (lane 2), 80pg (lane 3) and 8pg (lane 4) of
template plasmid (pIVEX-AGT-GST, 4.7kbp) were incubated for 1h. The products were run on an agarose gel (1%) and the ampliﬁcation factors
[shown at the bottom of (B)] were determined by qPCR.
Figure 5. Ampliﬁcation from crude E. coli lysates. cNDA was carried
out on three colonies (each containing  60000 cells) transformed with
pIVEX-RFP. No band was detected from crude lysates without amp-
liﬁcation (data not shown).
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Consistent with this observation the average product
length appears to increase when the rNTP concentration
is decreased in T4 pWGA (Supplementary Figure S6). A
concentration of 100mM for each rNTP was used in sub-
sequent T4 pWGA reactions along with 2mM ATP as
an energy source for clamp loader and helicase.
Successful product formation was observed when T4
pWGA was carried out with a variety of templates: a
covalently closed circular plasmid, a nicked plasmid
and human genomic DNA (Supplementary Figure S7).
The T4 replisome cannot initiate DNA synthesis on a
covalently closed circular plasmid. Although puriﬁed
plasmid DNA is mainly in the covalently circular
closed form, a small fraction is also nicked. This
fraction seems to be the template for the exponential
ampliﬁcation by T4 pWGA. This assumption is consist-
ent with the observation that more product was obtained
when the fraction of nicked plasmid was increased by
heating the plasmid or by deliberately nicking the
plasmid with a nicking endonuclease. In contrast to co-
valently closed circular templates, linear DNA can be
Figure 7. Immobilization of cNDA products. (A) cNDA reactions of pIVEX-PTE were performed with a non-biotinylated (b1, lane 1) and a
biotinylated primer (biotin-b1, lane 2). (B) Reaction products from cNDAs with 10ng or 1ng pIVEX-PTE as template using primers b1 or
biotin-b1 were immobilized on streptavidin-coated beads and added to IVTT mixtures. The activity of the expressed phosphotriesterase was
assayed by hydrolysis of the substrate paraoxon. Red closed circles: 10ng template DNA and biotin-b1 primer; green closed triangles: 1ng
template DNA and biotin-b1 primer; black open squares: 10ng template DNA and untagged b1 primer.
Figure 6. cNDA followed by IVTT. The plasmid pIVEX-PTE [0.66ng in (A) or 0.066ng in (B)] was ampliﬁed by cNDA. Then, an IVTT mixture
was added and PTE was expressed. Its activity was assayed by hydrolysis of the substrate paraoxon giving 4-nitrophenolate. The black progress
curves (open squares) resulted from ampliﬁed DNA, whereas the red progress curves (closed circles) were from controls without DNA ampliﬁcation.
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ﬁcation efﬁciency was observed when linear genomic
DNA was heated prior to T4 pWGA.
Sequencing of T4 pWGA products
The suitability of T4 pWGA products for sequencing was
assessed. Three commercially available plasmids
(Supplementary Table S1) were ampliﬁed from 4ng
DNA in 100ml reaction mixture without prior nicking or
heating. Ampliﬁcation products were puriﬁed with a puri-
ﬁcation kit for long DNA fragments (QIAEX II kit,
Qiagen) and sequenced with standard sequencing
primers (Supplementary Table S1). Each plasmid was
sequenced in the two opposite directions.
A representative sequencing result is shown in
Supplementary Figure S8. The data display the typical
pattern of a sequencing chromatogram, suggesting that
the T4 pWGA product is of suitable quality. The lengths
of accurate sequencing reads ranged from 724 to 819bp
and are comparable to sequence reads typically achieved
in the sequencing of puriﬁed plasmids (Supplementary
Table S1).
Ampliﬁcation bias of T4 pWGA
An important benchmark of every WGA system is its
ability to represent the complete genome with minimal
ampliﬁcation bias. The ampliﬁcation bias of T4 pWGA
was examined by qPCR for eight loci that cover
single-nucleotide polymorphisms (SNPs), each located
on a different chromosome (Table 2) (39). For compari-
son, the same experiments were performed for pWGA by
the T7 replisome and for MDA by the Phi29 DNA
polymerase (using the commercial Rapisome pWGA Kit
and illustra GenomiPhi V2 DNA Ampliﬁcation Kit,
respectively). With each system, 0.3, 1 or 10ng of
puriﬁed human genomic DNA were ampliﬁed. T4
pWGA and Rapisome pWGA reactions were incubated
at 37 C for 60min, whereas MDA reactions were
incubated at 30 C for 90min. The measured ampliﬁcation
biases of T4 pWGA were 4.8, 9.8 and 6.1 for 0.3, 1 and
10ng of input DNA, respectively (Table 3 and
Supplementary Table S2). This ratio varied only 2-fold
for three different amounts of input DNA (0.3, 1 and
10ng). In contrast, the ampliﬁcation biases for MDA
ranged between 5.7 and 20 and between 8.4 and 22 for
Rapisome pWGA. Average ampliﬁcation factors of T4
pWGA increased with decreasing input DNA reaching
210-fold for 0.3ng input DNA. The same trend was
observed for MDA, whereas the ampliﬁcation factor of
Rapisome pWGA decreased with decreasing input DNA
ampliﬁcation under these experimental conditions.
Quantitative T4 pWGA
As for cNDA it is also possible to monitor T4 pWGA in
real time. T4 pWGA reactions containing 1, 0.1, 0.01 and
0.001ng of genomic DNA and EvaGreen (37) were per-
formed and the ﬂuorescence was recorded. Figure 9A
shows the normalized real-time ampliﬁcation signal of
T4 pWGA. In analogy to qPCR, a ﬂuorescence threshold
was deﬁned. The times at which the T4 pWGA reactions
crossed the threshold (TT) were plotted against the
amount of input DNA in log scale and ﬁtted to a linear
equation (Figure 9B). The squared correlation coefﬁcient
(R
2) of 0.991 indicates a good correlation between the
amount of input DNA and the time to cross the threshold
over four orders of magnitude. The product of the
reaction accumulated exponentially and the slope of the
linear ﬁt indicates that the product increased 10-fold every
Table 3. Ampliﬁcation factors and biases
Ampliﬁcation system T4 pWGA Rapisome
pWGA
MDA T4 pWGA Rapisome
pWGA
MDA T4 pWGA Rapisome
pWGA
MDA
Input DNA (ng) 0.3 0.3 0.3 1 1 1 10 10 10
Ampliﬁcation factor±SD
a 210±55 170±110 3000±550 80±7 250±110 1700±920 20±1 310±42 190±37
Ampliﬁcation bias
b 4.8 8.4 9.2 9.8 22 20 6.1 11 5.7
aDNA amounts were measured by qPCR.
Ampliﬁcation factors and standard deviations (SDs) were calculated from triplicates of the WGA reactions for eight loci (Tables 2 and S2).
The averaged ampliﬁcation factors represent the mean of the ampliﬁcation factors over the eight loci analysed and the SDs represent the pooled
standard deviation of the SDs in individual loci (Supplementary Table S2).
bThe ampliﬁcation bias was calculated as the ratio of the highest to the lowest ampliﬁcation factor among the eight loci.
Figure 8. T4 pWGA product. Human genomic DNA (10ng) was used
as the template. The ampliﬁcation yields products of different lengths.
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reported for the T7 replisome (22). The detection limit
was 1pg, as lower amounts of DNA could not be distin-
guished from controls with no added template. Minute
contamination of the T4 replisome proteins with DNA
is the likely source of contamination acting as alternative
template.
DISCUSSION
A new isothermal ampliﬁcation system
The complete T4 replication machinery consists of eight
proteins (Figure 1) that perform the multistep process of
DNA ampliﬁcation, namely, the assembly of accessory
factors and the polymerase into a functional holoenzyme,
the separation of the double-stranded template DNA by
the helicase and RNA primer synthesis by the primase to
initiate DNA synthesis by the DNA polymerase. This
process had previously been reconstituted in vitro for
detailed mechanistic studies (23). In this study, the
reconstituted T4 bacteriophage replication machinery
was assessed as a truly isothermal DNA ampliﬁcation
method for various biotechnological applications.
cNDA
The cNDA ampliﬁcation mechanism (Figure 2) produces
a well-deﬁned uniform product as the cNDA reaction
involves a sequence-speciﬁc primer and a nicking
endonuclease. This mechanism is similar to the rolling
circle replication of phages and plasmids (42,43) where
an initiator protein nicks the circular template to initiate
ampliﬁcation. Other isothermal DNA ampliﬁcation
methods such as strand displacement ampliﬁcation
(SDA) (8,9), isothermal and chimeric primer-initiated
ampliﬁcation of nucleic acids (ICAN) (44) and primer gen-
eration–rolling circle ampliﬁcation (PG–RCA) (45) also
involve a nicking endonuclease, but are not suitable for
amplifying whole plasmids. Methods for amplifying whole
plasmids reported thus far generate a mixture of products.
The products of multiply primed RCA (14) and pWGA
(22) are branched and of multiple lengths, whereas cHDA
(21) yields concatemers of the circular DNA template in
addition to a speciﬁc product ﬂanked by two primers. In
cNDA, speciﬁcity is provided by the reverse primer and
the nicking endonuclease, whereas in multiply primed
RCA (14) and pWGA (22) any plasmid may be ampliﬁed.
Although the mechanism of cNDA does not involve
Figure 9. Real-time quantitative T4 pWGA. (A) Normalized real-time ampliﬁcation signal of T4 pWGA containing 1ng (red), 100pg (blue), 10pg
(green), 1pg (purple) and 0 (NTC; no template control; brown) human genomic DNA on a logarithmic scale. The threshold used for the quanti-
ﬁcation is drawn as a black line. (B) The time it took to cross the threshold (TT) was plotted against the amount of input DNA. The blue circles are
the samples containing input DNA and the red circles correspond to controls with no template. The linear ﬁt (black line) corresponds to the
following equation: TT= –13.01 log10[input DNA] + 37.47 (R
2=0.991).
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processivity of the T4 replisome [up to 250nt/s (24,25)
and longer than 20kbp (25)] leads to a substantial
amount of ampliﬁcation as evidenced by a plasmid
(4.7kbp) being ampliﬁed up to 1100-fold within 1h. This
is only 3.3-fold less than the highest reported ampliﬁcation
factor of cHDA after a 6-h incubation with 156pg input
DNA (21). Replacement of the T4 replisome by the Phi29
DNA polymerase (13) in cNDA did not yield product
detectable by gel electrophoresis, consistent with the low
linear ampliﬁcation of plasmids (20 copies per hour)
reported by Dean et al. (14). As no high-molecular-weight
concatemers are formed in cNDA, the amplicon is directly
accessible without the need for a post-ampliﬁcation re-
striction digest.
An exonuclease-deﬁcient variant of the T4 DNA
polymerase (gp43 [D219A]) (26) was used in this study.
This variant was chosen because the wild-type enzyme has
a strong 30!50 exonuclease activity. The wild-type T4
DNA polymerase has a very low error rate of 9.4 10
 7
per nucleotide incorporated, while the ﬁdelity of the
[D219A] mutant is slightly reduced at 4 10
 5
misincorporations per nucleotide added (46). Still, this
error rate compares well to the error rates of 4.4 10
 5
for the exonuclease deﬁcient T7 DNA polymerase
(Sequenase) (47), 7.2 10
 5 for Taq DNA polymerase
(47) and 10
 5 to 10
 6 for Phi29 DNA polymerase (48).
As cNDA does not involve exponential ampliﬁcation, any
error introduced is not propagated. However, to further
increase ﬁdelity it might be possible to add a DNA poly-
merase with proofreading activity to the reaction. This
could, for example, be the wild-type T4 DNA polymerase.
In fact, the Rapisome pWGA mixture also includes
wild-type T7 DNA polymerase as well an
exonuclease-deﬁcient variant (22).
Potential applications of cNDA
A number of applications could beneﬁt from rapid amp-
liﬁcation of plasmids producing a well-deﬁned product.
DNA ampliﬁcation prior to IVTT. Protein expression by
IVTT is widely used for high-throughput screening
formats including phenotyping of genes of interest,
directed evolution, protein truncation tests for mutation
detection and proteome analysis (49,50). However,
preparing sufﬁcient amounts of pure template DNA for
the IVTT can be cumbersome, especially for
high-throughput applications with many different tem-
plates. A DNA ampliﬁcation step prior to IVTT could
reduce the amount of input DNA required and increase
protein yields of IVTT. An increase of up to 67-fold in the
detected enzyme activity was observed after IVTT from
cNDA products compared to IVTT from non-ampliﬁed
DNA (Figure 6). This observation suggests that this
method could be applied prior to IVTT in
high-throughput screening formats. Such high-throughput
screening approaches are increasingly miniaturized, for
example, in water-in-oil emulsion droplets handled in
microﬂuidic devices (51). The avoidance of thermal
cycling and an initial heat denaturation step offer the
prospect of less complex microﬂuidic devices when
cNDA is used.
Screening bacterial colonies. cNDA can be carried out
directly on plasmids from single colonies of bacteria.
This suggests that cNDA could be used for screening bac-
terial colonies for the presence of a speciﬁc plasmid
without prior puriﬁcation.
Labeling strategies based on cNDA. Functional tags such
as ﬂuorescent dyes or biotin can be readily introduced into
the ampliﬁed DNA product at deﬁned positions by using a
labeled reverse primer. Here, we demonstrated the incorp-
oration of a biotin into the ampliﬁcation products and the
immobilization of the products on streptavidin-coated
microbeads (Figure 7). Immobilization of the ampliﬁca-
tion product is also a convenient way for puriﬁcation of
the cNDA product. For example, tagged DNA could be
puriﬁed from bacterial genomic DNA when the reaction is
performed from crude cell lysate. The T4 DNA polymer-
ase also allows incorporation of modiﬁed nucleotides
such as ﬂuorescein-dCTP (Supplementary Figure S4).
Simultaneous ampliﬁcation and labeling could provide a
convenient way for the generation of ﬂuorescent probes,
for example, for ﬂuorescence in situ hybridization
(FISH) (52).
Primase-based WGA using the T4 replisome
DNA ampliﬁcation is necessary for genotyping of samples
where the amount of available DNA is limited, as is fre-
quently encountered in diagnostics, forensics, clinical
pathology and archaeology. The ampliﬁcation step must
capture the 3 10
9bp of the human genome uniformly to
avoid loss and under-representation of loci or alleles.
Biased ampliﬁcation reduces representation of the
original template and distorts subsequent testing
results (53).
Degenerate oligonucleotide primers (DOPs) (3,4) or
primer extension preampliﬁcation (PEP) (5) PCR-based
WGA methods have ampliﬁcation biases as high as 10
6
and 10
4, respectively (2). Isothermal DNA ampliﬁcation
has been shown to yield more representative copies of
the genome (2,22,39) with typical ampliﬁcation biases
between 3- and 40-fold (2).
Two isothermal methods for WGA have been reported
so far: MDA (2) achieves exponential ampliﬁcation of
genomic DNA via a cascade of priming events by
random hexameric primers extended by the Phi29 DNA
polymerase. The use of random primers usually requires
an initial heat or chemical DNA denaturation step to
facilitate primer annealing (54,55). This additional step
adds labour to the protocol as well as an additional
source of DNA contamination and damage (2). In
addition, artifactual DNA synthesis and increased ampli-
ﬁcation bias have been observed in samples that have been
heat denatured (2).
In nature, RNA primers are synthesized by primases
and are subsequently elongated by DNA polymerases
(23). The mechanism of pWGA has recently been
demonstrated with the T7 replisome in which the gene 4
protein (gp4) has both primase and helicase activities (22).
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denaturation step to facilitate their annealing can be
overcome by synthesizing the primers on template DNA.
In this study, we showed that the T4 replisome with its
primase (gp61) can also support exponential
primase-based ampliﬁcation of genomic DNA and
plasmids resulting in products of different lengths
(Figure 8). To probe the utility of this method for DNA
analysis, the products of three T4 pWGA reactions with
plasmids as templates were sequenced. The read lengths
of 724–819bp were comparable to those typically achieved
by sequencing plasmids (Supplementary Table S1).
This demonstrates that the T4 pWGA products are long
enough for Sanger sequencing applications.
Ampliﬁcation factors and biases of T4 pWGA. T4 pWGA
reactions with human genomic template DNA resulted in
low ampliﬁcation biases between 4.8 and 9.8 among eight
loci for three different amounts of input DNA (0.3, 1 and
10ng) (Table 3), suggesting that ampliﬁcation biases of
this system are at least as good as the ampliﬁcation
biases of the two commercial isothermal WGA systems
(Rapisome pWGA kit, Biohelix and illustra GenomiPhi
V2 DNA Ampliﬁcation Kit, GE Healthcare) tested here.
For the lowest amount of input DNA (0.3ng) the 210-fold
ampliﬁcation achieved by T4 pWGA was comparable to
the 180-fold ampliﬁcation by the Rapisome pWGA,
whereas at the higher input DNA conditions tested, the
Rapisome pWGA and the illustra GenomiPhi V2 DNA
Ampliﬁcation Kit had better yields than the T4 pWGA.
Finally, in our hands, the T4 pWGA showed the highest
reproducibility of the three ampliﬁcation systems with the
lowest SDs over the three replicates.
DNA quantiﬁcation. Both cNDA and T4 pWGA reac-
tions could be monitored in real time by recording the
ﬂuorescence of EvaGreen (37) when bound to the
ampliﬁed DNA (Figures 4A and 9). For the exponential
T4 pWGA ampliﬁcation mechanism a good correl-
ation between the amount of input DNA and the time
to reach an arbitrary ﬂuorescence threshold was
obtained by treating the data in analogy to qPCR data.
These observations suggest that T4 pWGA could
be used for sequence-independent quantiﬁcation of
genomic DNA, as also has been shown for Rapisome
pWGA (22).
Further prospects for adaptation. Further improvement of
T4 pWGA ampliﬁcation factors may be achieved by
careful adjustment of the concentrations of the T4
replisome proteins and possible additional factors such
as pyrophosphatase (to prevent accumulation of inhibi-
tory pyrophosphate). Previous optimization of MDA
gives an idea of the potential: initial publications (2,39)
used incubation times of 16–18h, whereas a currently
available commercial kit can achieve similar yields
within 90min (54). A system composed of eight proteins
might seem daunting, but robust ampliﬁcation in a variety
of different buffers was observed (data not shown). The
segregation of the different functions necessary for DNA
replication into eight proteins also provides the potential
to differentially adjust individual components and
optimize this system for different applications. This will
be less likely if only a polymerase with strand-
displacement activity (such as Phi29 DNA polymerase)
is used. For example, different concentrations of the holo-
enzyme (gp43, gp45 and gp44/62) were used for the cNDA
reactions and the T4 pWGA reactions. Moreover, these
adjustments can be guided by the mechanistic insights that
have been gained during the extensive research on this
model system for DNA replication (23).
Taken together, these data characterize DNA ampliﬁ-
cation by the T4 replisome system as suitable for a variety
of applications. In addition to one of the fastest DNA
polymerases known, seven additional proteins constitute
the replisome, allowing sufﬁcient ﬂexibility for further
adaptation. Two different ampliﬁcation mechanisms
have been demonstrated: linear ampliﬁcation of plasmids
in the presence of a nicking endonuclease to yield
well-deﬁned products (cNDA) and an exponential ampli-
ﬁcation of genomic DNA that is primed by the T4 primase
(T4 pWGA). This robust, versatile and fast system for
isothermal DNA ampliﬁcation will be a useful alternative
to the current commercially exclusive systems.
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Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Philipp Savakis for performing preliminary ex-
periments, Philipp Hennig for advice on statistics and
Andrew Grifﬁths for the pIVEX-PTE plasmid.
FUNDING
Ernst Schering Foundation and the Cambridge Overseas
Trust and Trinity Hall, Cambridge (to Y.S.); Trinity
College, Cambridge, and the Biotechnology and
Biological Sciences Research Council (BBSRC) (to V.S.);
a Human Frontier Science Program grant and US
National Institutes of Health grant GM013306 (to
S.J.B.); EU NEST MiFem and an RCUK Basic
Technology Grant. F.H. is an ERC Starting
Investigator. Funding for open access charge: RCUK
Basic Technology grant.
Conﬂict of interest statement. None declared.
REFERENCES
1. Mullis,K., Faloona,F., Scharf,S., Saiki,R., Horn,G. and Erlich,H.
(1986) Speciﬁc enzymatic ampliﬁcation of DNA in vitro: the
polymerase chain reaction. Cold Spring Harb. Symp. Quant. Biol.,
51, 263–273.
2. Dean,F.B., Hosono,S., Fang,L., Wu,X., Faruqi,A.F.,
Bray-Ward,P., Sun,Z., Zong,Q., Du,Y., Du,J. et al. (2002)
Comprehensive human genome ampliﬁcation using multiple
displacement ampliﬁcation. Proc. Natl Acad. Sci. USA, 99,
5261–5266.
PAGE 13 OF 15 Nucleic Acids Research, 2010,Vol.38, No. 22 e2013. Telenius,H., Carter,N.P., Bebb,C.E., Nordenskjo ¨ ld,M.,
Ponder,B.A. and Tunnacliffe,A. (1992) Degenerate
oligonucleotide-primed PCR: general ampliﬁcation of target DNA
by a single degenerate primer. Genomics, 13, 718–725.
4. Cheung,V.G. and Nelson,S.F. (1996) Whole genome ampliﬁcation
using a degenerate oligonucleotide primer allows hundreds of
genotypes to be performed on less than one nanogram of
genomic DNA. Proc. Natl Acad. Sci. USA, 93, 14676–14679.
5. Zhang,L., Cui,X., Schmitt,K., Hubert,R., Navidi,W. and
Arnheim,N. (1992) Whole genome ampliﬁcation from a single
cell: implications for genetic analysis. Proc. Natl Acad. Sci. USA,
89, 5847–5851.
6. Jeong,Y.-J., Park,K. and Kim,D.-E. (2009) Isothermal DNA
ampliﬁcation in vitro: the helicase-dependent ampliﬁcation system.
Cell. Mol. Life Sci., 66, 3325–3336.
7. Gill,P. and Ghaemi,A. (2008) Nucleic acid isothermal
ampliﬁcation technologies: a review. Nucleos. Nucleot. Nucl., 27,
224–243.
8. Walker,G.T., Fraiser,M.S., Schram,J.L., Little,M.C., Nadeau,J.G.
and Malinowski,D.P. (1992) Strand displacement ampliﬁcation–an
isothermal, in vitro DNA ampliﬁcation technique. Nucleic Acids
Res., 20, 1691–1696.
9. Walker,G.T. (1993) Empirical aspects of strand displacement
ampliﬁcation. PCR Methods Appl., 3, 1–6.
10. Notomi,T., Okayama,H., Masubuchi,H., Yonekawa,T.,
Watanabe,K., Amino,N. and Hase,T. (2000) Loop-mediated
isothermal ampliﬁcation of DNA. Nucleic Acids Res., 28, e63.
11. Tomita,N., Mori,Y., Kanda,H. and Notomi,T. (2008)
Loop-mediated isothermal ampliﬁcation (LAMP) of gene
sequences and simple visual detection of products. Nat. Protoc.,
3, 877–882.
12. Lizardi,P.M., Huang,X., Zhu,Z., Bray-Ward,P., Thomas,D.C. and
Ward,D.C. (1998) Mutation detection and single-molecule
counting using isothermal rolling-circle ampliﬁcation. Nat. Genet.,
19, 225–232.
13. Blanco,L., Bernad,A., La ´ zaro,J.M., Martı´n,G., Garmendia,C. and
Salas,M. (1989) Highly efﬁcient DNA synthesis by the phage phi
29 DNA polymerase. Symmetrical mode of DNA replication.
J. Biol. Chem., 264, 8935–8940.
14. Dean,F.B., Nelson,J.R., Giesler,T.L. and Lasken,R.S. (2001)
Rapid ampliﬁcation of plasmid and phage DNA using Phi 29
DNA polymerase and multiply-primed rolling circle ampliﬁcation.
Genome Res., 11, 1095–1099.
15. Langmore,J.P. (2002) Rubicon Genomics, Inc. Pharmacogenomics,
3, 557–560.
16. SigmaGenomePlex Whole Genome Ampliﬁcation (WGA) Kit
manual (2007).
17. Barker,D.L., Hansen,M.S.T., Faruqi,A.F., Giannola,D.,
Irsula,O.R., Lasken,R.S., Latterich,M., Makarov,V., Oliphant,A.,
Pinter,J.H. et al. (2004) Two methods of whole-genome
ampliﬁcation enable accurate genotyping across a 2320-SNP
linkage panel. Genome Res., 14, 901–907.
18. Vincent,M., Xu,Y. and Kong,H. (2004) Helicase-dependent
isothermal DNA ampliﬁcation. EMBO Rep., 5, 795–800.
19. An,L., Tang,W., Ranalli,T.A., Kim,H.-J., Wytiaz,J. and Kong,H.
(2005) Characterization of a thermostable UvrD helicase and its
participation in helicase-dependent ampliﬁcation. J. Biol. Chem.,
280, 28952–28958.
20. Motre ´ ,A., Li,Y. and Kong,H. (2008) Enhancing
helicase-dependent ampliﬁcation by fusing the helicase with the
DNA polymerase. Gene, 420, 17–22.
21. Xu,Y., Jin Kim,H., Kays,A., Rice,J. and Kong,H. (2006)
Simultaneous ampliﬁcation and screening of whole
plasmids using the T7 bacteriophage replisome. Nucleic Acids
Res., 34, e98.
22. Li,Y., Kim,H.-J., Zheng,C., Chow,W.H.A., Lim,J., Keenan,B.,
Pan,X., Lemieux,B. and Kong,H. (2008) Primase-based whole
genome ampliﬁcation. Nucleic Acids Res., 36, e79.
23. Benkovic,S.J., Valentine,A.M. and Salinas,F. (2001)
Replisome-mediated DNA replication. Annu. Rev. Biochem., 70,
181–208.
24. Mace,D.C. and Alberts,B.M. (1984) T4 DNA polymerase. Rates
and processivity on single-stranded DNA templates. J. Mol. Biol.,
177, 295–311.
25. Cha,T.A. and Alberts,B.M. (1989) The bacteriophage T4 DNA
replication fork. Only DNA helicase is required for leading strand
DNA synthesis by the DNA polymerase holoenzyme. J. Biol.
Chem., 264, 12220–12225.
26. Frey,M.W., Nossal,N.G., Capson,T.L. and Benkovic,S.J. (1993)
Construction and characterization of a bacteriophage T4 DNA
polymerase deﬁcient in 30–>50 exonuclease activity. Proc. Natl
Acad. Sci. USA, 90, 2579–2583.
27. Schrock,R.D. and Alberts,B. (1996) Processivity of the gene 41
DNA helicase at the bacteriophage T4 DNA replication fork.
J. Biol. Chem., 271, 16678–16682.
28. Valentine,A.M., Ishmael,F.T., Shier,V.K. and Benkovic,S.J. (2001)
A zinc ribbon protein in DNA replication: primer synthesis and
macromolecular interactions by the bacteriophage T4 primase.
Biochemistry, 40, 15074–15085.
29. Ishmael,F.T., Alley,S.C. and Benkovic,S.J. (2001) Identiﬁcation
and mapping of protein-protein interactions between gp32 and
gp59 by cross-linking. J. Biol. Chem., 276, 25236–25242.
30. Rush,J., Lin,T.C., Quinones,M., Spicer,E.K., Douglas,I.,
Williams,K.R. and Konigsberg,W.H. (1989) The 44P subunit of
the T4 DNA polymerase accessory protein complex catalyzes
ATP hydrolysis. J. Biol. Chem., 264, 10943–10953.
31. Ishmael,F.T., Alley,S.C. and Benkovic,S.J. (2002) Assembly
of the bacteriophage T4 helicase: architecture and
stoichiometry of the gp41-gp59 complex. J. Biol. Chem., 277,
20555–20562.
32. Courtois,F., Olguin,L.F., Whyte,G., Bratton,D., Huck,W.T.S.,
Abell,C. and Hollfelder,F. (2008) An integrated device for
monitoring time-dependent in vitro expression from single genes
in picolitre droplets. ChemBioChem, 9, 439–446.
33. Courtois,F., Olguin,L.F., Whyte,G., Theberge,A.B., Huck,W.T.S.,
Hollfelder,F. and Abell,C. (2009) Controlling the retention of
small molecules in emulsion microdroplets for use in cell-based
assays. Anal. Chem., 81, 3008–3016.
34. Campbell,R.E., Tour,O., Palmer,A.E., Steinbach,P.A.,
Baird,G.S., ZachFarias,D.A. and Tsien,R.Y. (2002) A
monomeric red ﬂuorescent protein. Proc. Natl Acad. Sci. USA,
99, 7877–7882.
35. Stein,V., Sielaff,I., Johnsson,K. and Hollfelder,F. (2007) A
covalent chemical genotype-phenotype linkage for in vitro protein
evolution. ChemBioChem, 8, 2191–2194.
36. Kelly,B.T. and Grifﬁths,A.D. (2007) Selective gene ampliﬁcation.
Protein Eng. Des. Sel., 20, 577–581.
37. Mao,F., Leung,W.-Y. and Xin,X. (2007) Characterization of
EvaGreen and the implication of its physicochemical properties
for qPCR applications. BMC Biotechnol., 7, 76.
38. Grifﬁths,A.D. and Tawﬁk,D.S. (2003) Directed evolution of an
extremely fast phosphotriesterase by in vitro
compartmentalization. EMBO J., 22, 24–35.
39. Hosono,S., Faruqi,A.F., Dean,F.B., Du,Y., Sun,Z., Wu,X., Du,J.,
Kingsmore,S.F., Egholm,M. and Lasken,R.S. (2003) Unbiased
whole-genome ampliﬁcation directly from clinical samples.
Genome Res., 13, 954–964.
40. Yang,J., Trakselis,M.A., Roccasecca,R.M. and Benkovic,S.J.
(2003) The application of a minicircle substrate in the study of
the coordinated T4 DNA replication. J. Biol. Chem., 278,
49828–49838.
41. Nelson,S.W., Kumar,R. and Benkovic,S.J. (2008) RNA primer
handoff in bacteriophage T4 DNA replication: the role of
single-stranded DNA-binding protein and polymerase accessory
proteins. J. Biol. Chem., 283, 22838–22846.
42. Novick,R.P. (1998) Contrasting lifestyles of rolling-circle phages
and plasmids. Trends Biochem. Sci., 23, 434–438.
43. Khan,S.A. (2005) Plasmid rolling-circle replication: highlights of
two decades of research. Plasmid, 53, 126–136.
44. Uemori,T., Mukai,H., Takeda,O., Moriyama,M., Sato,Y.,
Hokazono,S., Takatsu,N., Asada,K. and Kato,I. (2007)
Investigation of the molecular mechanism of ICAN, a novel gene
ampliﬁcation method. J. Biochem., 142, 283–292.
45. Murakami,T., Sumaoka,J. and Komiyama,M. (2009)
Sensitive isothermal detection of nucleic-acid sequence by
primer generation-rolling circle ampliﬁcation. Nucleic Acids Res.,
37, e19.
e201 Nucleic Acids Research, 2010,Vol.38, No. 22 PAGE 14 OF 1546. Kroutil,L.C., Frey,M.W., Kaboord,B.F., Kunkel,T.A. and
Benkovic,S.J. (1998) Effect of accessory proteins on T4
DNA polymerase replication ﬁdelity. J. Mol. Biol., 278,
135–146.
47. Ling,L.L., Keohavong,P., Dias,C. and Thilly,W.G. (1991)
Optimization of the polymerase chain reaction with regard to
ﬁdelity: modiﬁed T7, Taq, and vent DNA polymerases. PCR
Methods Appl., 1, 63–69.
48. Esteban,J.A., Salas,M. and Blanco,L. (1993) Fidelity of phi 29
DNA polymerase. Comparison between protein-primed
initiation and DNA polymerization. J. Biol. Chem., 268,
2719–2726.
49. Grandi,G. (ed.), (2007), ‘‘In vitro transcription and translation
protocols’’, Methods in Molecular Biology, Vol. 375. Humana Press,
Totowa, New Jersey.
50. Leemhuis,H., Stein,V., Grifﬁths,A.D. and Hollfelder,F. (2005)
New genotype-phenotype linkages for directed evolution of
functional proteins. Curr. Opin. Struct. Biol., 15, 472–478.
51. Schaerli,Y. and Hollfelder,F. (2009) The potential of microﬂuidic
water-in-oil droplets in experimental biology. Mol. BioSyst., 5,
1392–1404.
52. Volpi,E.V. and Bridger,J.M. (2008) FISH glossary: an overview
of the ﬂuorescence in situ hybridization technique. BioTechniques,
45, 385–409.
53. Lasken,R.S. and Egholm,M. (2003) Whole genome ampliﬁcation:
abundant supplies of DNA from precious samples or clinical
specimens. Trends Biotechnol., 21, 531–535.
54. GE Healthcare, illustra GenomiPhi V2 DNA Ampliﬁcation Kit
manual (2009).
55. QIAGEN, REPLI-g Mini/Midi Handbook (2008).
PAGE 15 OF 15 Nucleic Acids Research, 2010,Vol.38, No. 22 e201